Clinical trial Recruiting at 1 site Observational Ages 18 to 47

Long-term follow-up of fertility preservation in women after cancer remission

Official title: Long-term Evaluation of Fertility Preservation Options in Women in Cancer Remission or Haematological Pathology

Run by Centre Hospitalier Universitaire, Amiens · NCT07312058 · Data updated 2026-11-12

This project will see how fertility preservation options work long-term for women in remission from cancer or hematological disease, including how often preserved material is used and the psychological effects.

More Reproductive Health trials

Quick facts

Study typeObservational
Ages18 Years to 47 Years
SexAll
Enrollment102 (estimated)
SponsorCentre Hospitalier Universitaire, Amiens
Academic / other
Locations1 site (Amiens)
StatusRecruiting
StartedDecember 17, 2025
Main results expectedJanuary 2027
Study endsJanuary 2027
Registry record updatedJanuary 16, 2026
Trial IDNCT07312058 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18–47 who underwent a fertility preservation consultation, are currently in remission, and are followed at CHU Amiens Picardie are the intended participants.

Probably not a fit

Patients who are not in remission, are not followed at CHU Amiens Picardie, are male, or who did not have a fertility preservation consultation are unlikely to benefit from this project.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational project at CHU Amiens Picardie will document clinical pathways, decisions made at the time of fertility preservation consultation, the techniques used, and reproductive outcomes observed after remission. Researchers will collect clinical records and follow-up data and gather patient-reported information on use of preserved gametes and psychological impact. The cohort includes women aged 18–47 who had a fertility preservation consultation and are currently in remission. Findings aim to identify gaps in care and inform improvements in counseling and long-term follow-up.

Why it matters

Potential benefit: If successful, the work could improve counseling, follow-up care, and decision-making around fertility preservation for women treated with gonadotoxic therapies.

How similar studies have gone: Previous studies have reported some outcomes of fertility preservation, but long-term real-world use of preserved material and the psychological consequences remain relatively under-studied.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Women
* Aged between 18 and 47 years
* Diagnosed with cancer or hematological disorders requiring potentially gonadotoxic treatment
* Having undergone a medical fertility preservation consultation
* Followed at Amiens Picardie University Hospital (CHU Amiens Picardie) in the department of Reproductive Medicine
* Currently in remission
* Having expressed non-opposition to participation in the study

Exclusion Criteria:

* Absence of remission
* Patients deprived of liberty by administrative or judicial decision, or placed under legal protection (guardianship or curators)
* Decline to participate in the study

Where it's running

  • CHU Amiens Picardie
    Amiens, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.